Preliminary evidence supports the notion that COVID-19 patients may have an increased
susceptibility to develop venous thromboembolism (VTE). However, the magnitude of this …

Background Severely ill patients with SARS-CoV-2 have an increased risk of venous
thromboembolism (VTE) ie, deep vein thrombosis and pulmonary embolism. However, the …

Background: A high incidence of venous thromboembolism (VTE) is reported in hospitalized
COVID-19 patients, in particular in patients admitted to the intensive care unit (ICU). In …

Background COVID-19 related in-hospital venous thromboembolism (VTE) incidence is high
but data reported vary significantly. Some studies show that up to half of the events are …

Coronavirus disease 2019 (COVID-19) may have a wide spectrum of clinical presentations,
leading in some cases to a critical condition with poor long-term outcomes and residual …

Background High incidence of asymptomatic venous thromboembolism (VTE) has been
observed in severe COVID‐19 patients, but the characteristics of symptomatic VTE in …

Infection with coronavirus disease‐2019 (COVID‐19) may predispose for venous
thromboembolism (VTE). There is wide variation in reported incidence rates of VTE in …

Abstract Background Coronavirus disease 2019 (COVID‐19) can lead to systemic
coagulation activation and thrombotic complications. Objectives To investigate the incidence …

Background. Coronavirus disease 2019 (COVID‐19) can result in profound changes in
blood coagulation. The aim of the study was to determine the incidence and predictors of …

Patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
appear to be at increased risk for venous thromboembolism (VTE), especially if they become …